BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37274242)

  • 1. Little things with significant impact: miRNAs in hepatocellular carcinoma.
    Li J; Bao H; Huang Z; Liang Z; Wang M; Lin N; Ni C; Xu Y
    Front Oncol; 2023; 13():1191070. PubMed ID: 37274242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of MicroRNAs in Hepatocellular Carcinoma.
    Xu X; Tao Y; Shan L; Chen R; Jiang H; Qian Z; Cai F; Ma L; Yu Y
    J Cancer; 2018; 9(19):3557-3569. PubMed ID: 30310513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma.
    Khan S; Zhang DY; Zhang JY; Hayat MK; Ren J; Nasir S; Fawad M; Bai Q
    Front Oncol; 2022; 12():950374. PubMed ID: 35924150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA and liver cancer.
    Onishi M; Ochiya T; Tanaka Y
    Cancer Drug Resist; 2020; 3(3):385-400. PubMed ID: 35582451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers.
    El-Mahdy HA; Sallam AM; Ismail A; Elkhawaga SY; Elrebehy MA; Doghish AS
    Pathol Res Pract; 2022 May; 233():153886. PubMed ID: 35405621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma.
    Wang D; Chen F; Zeng T; Tang Q; Chen B; Chen L; Dong Y; Li X
    Genes Dis; 2021 Mar; 8(2):157-167. PubMed ID: 33997162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
    Zhou Y; Liu F; Ma C; Cheng Q
    J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H; Liu J; Zou R; Cheng P; Su Y
    J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.
    Chu R; Mo G; Duan Z; Huang M; Chang J; Li X; Liu P
    Cell Commun Signal; 2014 Jul; 12():45. PubMed ID: 25012758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.
    Greene CM; Varley RB; Lawless MW
    World J Gastroenterol; 2013 Aug; 19(32):5212-26. PubMed ID: 23983424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
    Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
    PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
    Zhao J; Wang Y; Su H; Su L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
    Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.
    Oura K; Morishita A; Masaki T
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.
    Khashkhashi Moghadam S; Bakhshinejad B; Khalafizadeh A; Mahmud Hussen B; Babashah S
    J Cell Mol Med; 2022 Jan; 26(2):287-305. PubMed ID: 34907642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.
    Cao J; Liu J; Long J; Fu J; Huang L; Li J; Liu C; Zhang X; Yan Y
    Biomed Pharmacother; 2017 May; 89():642-650. PubMed ID: 28262617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.